129 related articles for article (PubMed ID: 38587506)
1. Early Immunomodulatory Program Triggered by Protolerogenic Bifidobacterium pseudolongum Drives Cardiac Transplant Outcomes.
Gavzy SJ; Kensiski A; Saxena V; Lakhan R; Hittle L; Wu L; Iyyathurai J; Dhakal H; Lee ZL; Li L; Lee YS; Zhang T; Lwin HW; Shirkey MW; Paluskievicz CM; Piao W; Mongodin EF; Ma B; Bromberg JS
Transplantation; 2024 Jul; 108(7):e91-e105. PubMed ID: 38587506
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota-dependent modulation of innate immunity and lymph node remodeling affects cardiac allograft outcomes.
Bromberg JS; Hittle L; Xiong Y; Saxena V; Smyth EM; Li L; Zhang T; Wagner C; Fricke WF; Simon T; Brinkman CC; Mongodin EF
JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282817
[TBL] [Abstract][Full Text] [Related]
3. Strain-specific alterations in gut microbiome and host immune responses elicited by tolerogenic Bifidobacterium pseudolongum.
Ma B; Gavzy SJ; Saxena V; Song Y; Piao W; Lwin HW; Lakhan R; Iyyathurai J; Li L; France M; Paluskievicz C; Shirkey MW; Hittle L; Munawwar A; Mongodin EF; Bromberg JS
Sci Rep; 2023 Jan; 13(1):1023. PubMed ID: 36658194
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbial Metabolites Induce Donor-Specific Tolerance of Kidney Allografts through Induction of T Regulatory Cells by Short-Chain Fatty Acids.
Wu H; Singer J; Kwan TK; Loh YW; Wang C; Tan J; Li YJ; Lai SWC; Macia L; Alexander SI; Chadban SJ
J Am Soc Nephrol; 2020 Jul; 31(7):1445-1461. PubMed ID: 32482686
[TBL] [Abstract][Full Text] [Related]
5. Bifidobacterium pseudolongum reduces triglycerides by modulating gut microbiota in mice fed high-fat food.
Bo TB; Wen J; Zhao YC; Tian SJ; Zhang XY; Wang DH
J Steroid Biochem Mol Biol; 2020 Apr; 198():105602. PubMed ID: 31987886
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota and renal transplant outcome.
Ardalan M; Vahed SZ
Biomed Pharmacother; 2017 Jun; 90():229-236. PubMed ID: 28363168
[TBL] [Abstract][Full Text] [Related]
7. Berberine Promotes Induction of Immunological Tolerance to an Allograft via Downregulating Memory CD8
Qiu F; Lu W; Ye S; Liu H; Zeng Q; Huang H; Liang CL; Chen Y; Zheng F; Zhang Q; Lu CJ; Dai Z
Front Immunol; 2021; 12():646831. PubMed ID: 33643325
[TBL] [Abstract][Full Text] [Related]
8. Gut microbes contribute to variation in solid organ transplant outcomes in mice.
McIntosh CM; Chen L; Shaiber A; Eren AM; Alegre ML
Microbiome; 2018 May; 6(1):96. PubMed ID: 29793539
[TBL] [Abstract][Full Text] [Related]
9. Clostridium butyricum and Bifidobacterium pseudolongum Attenuate the Development of Cardiac Fibrosis in Mice.
Wang J; Chen J; Li L; Zhang H; Pang D; Ouyang H; Jin X; Tang X
Microbiol Spectr; 2022 Dec; 10(6):e0252422. PubMed ID: 36318049
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the Gut Microbiota With Antibiotics Exacerbates Acute Vascular Rejection.
Rey K; Manku S; Enns W; Van Rossum T; Bushell K; Morin RD; Brinkman FSL; Choy JC
Transplantation; 2018 Jul; 102(7):1085-1095. PubMed ID: 29538261
[TBL] [Abstract][Full Text] [Related]
11. Graft IL-33 regulates infiltrating macrophages to protect against chronic rejection.
Li T; Zhang Z; Bartolacci JG; Dwyer GK; Liu Q; Mathews LR; Velayutham M; Roessing AS; Lee YC; Dai H; Shiva S; Oberbarnscheidt MH; Dziki JL; Mullet SJ; Wendell SG; Wilkinson JD; Webber SA; Wood-Trageser M; Watkins SC; Demetris AJ; Hussey GS; Badylak SF; Turnquist HR
J Clin Invest; 2020 Oct; 130(10):5397-5412. PubMed ID: 32644975
[TBL] [Abstract][Full Text] [Related]
12. Tanshinol suppresses cardiac allograft rejection in a murine model.
Lu C; Zeng YQ; Liu H; Xie Q; Xu S; Tu K; Dou C; Dai Z
J Heart Lung Transplant; 2017 Feb; 36(2):227-236. PubMed ID: 27574736
[TBL] [Abstract][Full Text] [Related]
13. Loss of myeloid related protein-8/14 exacerbates cardiac allograft rejection.
Shimizu K; Libby P; Rocha VZ; Folco EJ; Shubiki R; Grabie N; Jang S; Lichtman AH; Shimizu A; Hogg N; Simon DI; Mitchell RN; Croce K
Circulation; 2011 Dec; 124(25):2920-32. PubMed ID: 22144572
[TBL] [Abstract][Full Text] [Related]
14. Early chemokine cascades in murine cardiac grafts regulate T cell recruitment and progression of acute allograft rejection.
Morita K; Miura M; Paolone DR; Engeman TM; Kapoor A; Remick DG; Fairchild RL
J Immunol; 2001 Sep; 167(5):2979-84. PubMed ID: 11509648
[TBL] [Abstract][Full Text] [Related]
15. Macrophage subpopulations and their impact on chronic allograft rejection versus graft acceptance in a mouse heart transplant model.
Zhao Y; Chen S; Lan P; Wu C; Dou Y; Xiao X; Zhang Z; Minze L; He X; Chen W; Li XC
Am J Transplant; 2018 Mar; 18(3):604-616. PubMed ID: 29044999
[TBL] [Abstract][Full Text] [Related]
16. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
17. Chronic Rejection of Cardiac Allografts Is Associated With Increased Lymphatic Flow and Cellular Trafficking.
Edwards LA; Nowocin AK; Jafari NV; Meader LL; Brown K; Sarde A; Lam C; Murray A; Wong W
Circulation; 2018 Jan; 137(5):488-503. PubMed ID: 28775077
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle PET-CT detects rejection and immunomodulation in cardiac allografts.
Ueno T; Dutta P; Keliher E; Leuschner F; Majmudar M; Marinelli B; Iwamoto Y; Figueiredo JL; Christen T; Swirski FK; Libby P; Weissleder R; Nahrendorf M
Circ Cardiovasc Imaging; 2013 Jul; 6(4):568-73. PubMed ID: 23771986
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
[TBL] [Abstract][Full Text] [Related]
20. The Probiotic Compound VSL#3 Modulates Mucosal, Peripheral, and Systemic Immunity Following Murine Broad-Spectrum Antibiotic Treatment.
Ekmekciu I; von Klitzing E; Fiebiger U; Neumann C; Bacher P; Scheffold A; Bereswill S; Heimesaat MM
Front Cell Infect Microbiol; 2017; 7():167. PubMed ID: 28529928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
